Skip to content
The Nexus
DossierENTITY

JECT

Coverage of JECT in the Nexus archive.

Earliest in view: May 26 · 12:43 UTCMost recent: May 26 · 12:43 UTC
Co-mentioned in this coverage
Ozempictopic1Mounjarotopic1Botoxtopic1GLP-1topic1FDAorganization1Joe Roganperson1IVFtopic1
Recent coverage
  • HEALTHMay 26 · 12:43 UTCTHE ATLANTIC
    Welcome to the Injection Age

    The article discusses the shift from pill-based to injection-based treatments in the U.S., highlighting the rise of GLP-1 drugs like Ozempic and Mounjaro for weight loss, increased use of Botox and IVF-related hormone injections, and the growth of 'needle-forward' wellness services. It notes the FDA approval of semaglutide in 2021 as a catalyst for the obesity medication trend, alongside cultural influences like Joe Rogan's promotion of peptides.